Haemonetics (HAE) PT Raised to $59 at Jefferies; Reiterates Buy
Jefferies raised its price target on Haemonetics (NYSE: HAE) to $59.00 (from $48.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
